With the US poised to lose its measles-free status, an expert from GeoVax discusses how to win back the minds of Americans.

Elemental impurity risk management can help biomanufacturers to maintain regulatory alignment and ensure patient safety.

Biopharmaceutical company Rakuten announced the signing of a manufacturing partnership with contract development and ...

North Carolina Governor Josh Stein announced that pharmaceutical giant Johnson & Johnson (J&J) will expand its presence in ...

Last week, biotechnology company Ascidian Therapeutics announced a manufacturing partnership with gene-therapy–focused ...

Meanwhile, Novotech has appointed Anand Tharmaratnam as its own new CEO. Tharmaratnam has over 30 years of industry ...

Validated next-generation sequencing soon will become necessary in ensuring the safety and efficacy of cell and gene ...

The Priority Review Voucher (PRV) program is designed to incentivize rare disease drug development.

Stéphane Bancel, CEO of vaccine maker Moderna, addressed shareholders in a letter that dissected the events of 2025 while ...

Ludwig Macko is head of development for Genedata's Selector software platform for NGS data analysis.

Valentina Armiento is science communications manager at Genedata.

But cell and gene therapies (CGTs) are catching up. During Cell and Gene Therapy International Europe 2025, held in Berlin, ...